Samsung Biologics, KAHR Medical Sign Strategic Agreement for Cancer Immunotherapy Drug June 3, 2021 Auto Bot News 0 Samsung Biologics and KAHR Medical have signed a strategic development and manufacturing agreement for a cancer immunotherapy drug candidate.